Asia Pacific Magnetic Resonance Imaging (MRI) Market By Type (Open MRI, Closed MRI)), Field Strength (High Field System, Medium Field System, Low Field System), Application (Brain and Neurological, Spine and Musculoskeletal, Vascular, Pelvic and Abdominal, Breast, Cardiac)
Special Offering: Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support
Get in-depth analysis of the COVID-19 impact on the Asia Pacific Magnetic Resonance Imaging (MRI) Market
The Asia Pacific Magnetic Resonance Imaging Market is expected to grow at a CAGR of 4.7% during 2016 -2022. Increase in Chronic Obstructive Pulmonary Disease (COPD) has also witnessed in the growth of the market. The main reason for cardiovascular diseases and COPD are increasing consumption of tobacco products, physical inactivity, air pollution, work pressure and change in diet plans. Rise in the incidence of diseases have initiated the organizations to take measures against the problem by spreading the awareness for early diagnosis. Rising awareness would ultimately enhance the market for MRI Systems.
The World Health Organisation (WHO) report states that there are certain health conditions that are expected to rise with the rise in ageing population, the conditions includes dementia, cancer, increase in the number of falls, obesity and diabetes. Owing to this need for MRI scan would be increasing in the market for the diagnosis or scan of the diseases. The report highlights the adoption of Magnetic Resonance Imaging (MRI) in Asia Pacific. Based on the Type, the Europe Magnetic Resonance Imaging Market is segmented into Open MRI and Closed MRI segment.
Based on the Field Strength, the market is bifurcated into High Field System, Medium Field System and Low Field System segments. Based on the Application, the market is bifurcated into Brain and Neurological MRI, Spine and Musculoskeletal MRI, Vascular MRI, Pelvic and Abdominal MRI, Breast MRI and Cardiac MRI segments.
The countries included in the report are China, Japan, India, South Korea, Singapore, Malaysia and Rest of Asia Pacific. Key Players profiled in the report includes General Electric, Siemens Healthcare, Philips Group, Hitachi Ltd., Toshiba Medical Systems Corporation, Shimadzu Corporation, Hologic Inc., Barco and Onex Corporation.